Home/Pipeline/ACD-101

ACD-101

Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Phase 1/2Active, RecruitingNCT055123XX

Key Facts

Indication
Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Phase
Phase 1/2
Status
Active, Recruiting
Company

About Advanced Cellular Dynamics

Advanced Cellular Dynamics is pioneering a new class of engineered cellular therapeutics focused on immune modulation and targeted cancer treatment. The company's core technology enables precise control over cell fate and function, aiming to create more persistent and potent therapies. With a pipeline advancing through early clinical development, ACD is positioned at the forefront of the next wave of cell therapy innovation. The company is backed by leading life science investors and maintains strategic research collaborations with academic institutions.

View full company profile

About Advanced Cellular Dynamics

Advanced Cellular Dynamics is pioneering a new class of engineered cellular therapeutics focused on immune modulation and targeted cancer treatment. The company's core technology enables precise control over cell fate and function, aiming to create more persistent and potent therapies. With a pipeline advancing through early clinical development, ACD is positioned at the forefront of the next wave of cell therapy innovation. The company is backed by leading life science investors and maintains strategic research collaborations with academic institutions.

View full company profile